Medical News

RSS

Health Canada approves Talecris Biotherapeutics' PROLASTIN-C for AAT deficiency

Talecris Biotherapeutics announced today that it has received approval from Health Canada for PROLASTIN®-C (Alpha1-Proteinase Inhibitor [Human]), a more purified and concentrated version of PROLASTIN® produced using advances in manufacturing technology. A similar approval for PROLASTIN-C was granted by the U.S. Food and Drug Administration on October 17, 2009.

17 Feb 2010

IH Systems selects Robotic IV Automation Systems for cytotoxic drug preparation

Following the successful integration of RIVA (Robotic IV Automation System) - a self-contained unit for filling IV syringes and bags - into three healthcare institutions in 2009, and the announcements of several more sales for installation in 2010, medical device company Intelligent Hospital Systems has confirmed the sale of three additional RIVA systems for cytotoxic drug preparation in 2010.

17 Feb 2010

White House hints at new health bill as GOP sees possible upside in summit

White House officials "hinted on Tuesday that President Obama might post his own [health care] bill on the Internet before the bipartisan health care summit he is planning" next week, The New York Times reports. "In the nearly a year since Congress began debating a health care overhaul, Mr. Obama has yet to make his own priorities explicit. He said at the outset that he would set broad parameters for the measure and leave the details to lawmakers." Obama said last week that hoped to post to the Internet a merged bill that would address costs and expand coverage.

17 Feb 2010

St. David's Healthcare to acquire Texas-based multi-hospital regional healthcare system

St. David's HealthCare and MedCath Corporation today announced an agreement for St. David's HealthCare to acquire the Heart Hospital of Austin. St. David's HealthCare is a multi-hospital regional healthcare system based in Austin, Texas.

17 Feb 2010

Senesco Technologies announces financial results for quarter ended December 31, 2009

Senesco Technologies, Inc. today reported financial results for the three months ended December 31, 2009.

17 Feb 2010

Tioga Pharmaceuticals to utilize $18M equity funding for Phase 3 clinical trial of asimadoline

Tioga Pharmaceuticals, Inc. today announced the closing of an $18 million equity financing. Current investors Forward Ventures, New Leaf Venture Partners and BB Biotech Ventures were joined by new investor Genesys Capital Partners.

17 Feb 2010

FDA clears Otonomy's IND for clinical trial of OTO-104 in Meniere's disease patients

Otonomy, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company's Investigational New Drug (IND) application for the clinical trial of OTO-104 in patients with Meniere's disease, a debilitating disorder of the inner ear affecting balance and hearing.

17 Feb 2010

Marcadia Biotech commences Phase 1 clinical trial of MAR701 for type 2 diabetes

Marcadia Biotech Inc. today announced that it has initiated a Phase 1 clinical trial of MAR701, a novel dual agonist of the incretin hormone receptors for glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Marcadia plans to initially develop this compound as a treatment for type 2 diabetes with once-weekly dosing. The Phase 1 trial will evaluate MAR701 in healthy volunteers at escalating dose levels.

17 Feb 2010

NABsys to utilize $7M Series B funding for accelerating DNA sequencing platform development

NABsys Inc., the pioneer in electronic, solid-state DNA sequencing, today announced that it has received a $7 million investment as part of a Series B equity round led by Stata Venture Partners. The funding will be used to accelerate the development and commercialization of the company’s proprietary DNA sequencing platform, which leverages semiconductor technology to achieve the scope and scale required for full integration of genomics into medicine.

17 Feb 2010

Wellstar International commences Beta Test in Long Term Care Facility

Wellstar International, Inc. has announced they have started the Beta Test in a Long Term Care Facility.

17 Feb 2010

Pharmatek Laboratories meets DEA requirements for developing and manufacturing controlled substances

Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has successfully met Drug Enforcement Agency (DEA) requirements to be registered for the development and manufacture of Schedule IV and V controlled substances.

17 Feb 2010

NMT Medical completes private placement of common stock and warrants for $5.8M

NMT Medical, Inc. today announced that it has completed a private placement of its common stock and warrants to purchase additional shares of common stock to existing and new stockholders for aggregate proceeds of approximately $5.8 million.

17 Feb 2010

Menopause supplement to bring body back into balance

Whitemark Homes, Inc., is pleased to announce a satisfaction guaranteed top selling product line by Ribbon Naturals Corp., complete system Menopause Solutions. A solution for women who are dissatisfied with the results they receive from common, everyday menopause supplements. Now there is a supplement for menopause that brings the body back into balance.

17 Feb 2010

MedCath to sell Heart Hospital of Austin to St. David's Healthcare Partnership

MedCath Corporation and its physician partners announced today that they have entered into a definitive agreement to sell substantially all the assets of Heart Hospital of Austin to St. David's Healthcare Partnership, L.P. ("St. David's"). The transaction is expected to close during MedCath's third fiscal quarter of 2010, subject to customary closing conditions and regulatory requirements.

17 Feb 2010

Domino's Pizza raises $2M during 2009 Thanks and Giving campaign for St. Jude Children's Research Hospital

Domino's Pizza, the recognized world leader in pizza delivery, raised $2 million for St. Jude Children's Research Hospital® during the 2009 Thanks and Giving® campaign. This marks the largest single charitable donation in the history of Domino's Pizza.

17 Feb 2010

Dyax announces fourth-quarter and full-year 2009 financial results

Dyax Corp. today announced financial results for the fourth quarter and year ended December 31, 2009. Dyax will host a webcast and conference call at 10 a.m. (ET) this morning to review the financial results and corporate progress for the quarter.

17 Feb 2010

Merge Healthcare signs reseller agreement with Orion Health

Merge Healthcare announced today that it has signed a reseller agreement with Orion Health, a leading provider of clinical workflow and integration solutions in healthcare. Orion Health has licensed Merge technology to bring medical images and information into its physician portal solutions.

17 Feb 2010

Anpath Group, ESI report increased quarterly revenues in fiscal third-quarter results

Anpath Group, Inc., and its wholly-owned subsidiary, EnviroSystems, Inc., today reported financial results for its fiscal 2010 third quarter which ended December 31, 2009.

17 Feb 2010

Fourth-quarter and full-year 2009 results announced by Celsion

Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.

17 Feb 2010

FDA approved cannabis medicines needed for veterans to relieve symptoms of PTSD

Cannabis Science Inc., an emerging pharmaceutical cannabis company, is reviewing interim results of its survey from over 1400 people, US military veterans and others who responded to our PTSD survey. The survey is still available for a limited time online on the www.cannabisscience.com website for all those who still wish to participate.

17 Feb 2010

Medical News

Health Canada approves Talecris Biotherapeutics' PROLASTIN-C for AAT deficiency

IH Systems selects Robotic IV Automation Systems for cytotoxic drug preparation

White House hints at new health bill as GOP sees possible upside in summit

St. David's Healthcare to acquire Texas-based multi-hospital regional healthcare system

Senesco Technologies announces financial results for quarter ended December 31, 2009

Tioga Pharmaceuticals to utilize $18M equity funding for Phase 3 clinical trial of asimadoline

FDA clears Otonomy's IND for clinical trial of OTO-104 in Meniere's disease patients

Marcadia Biotech commences Phase 1 clinical trial of MAR701 for type 2 diabetes

NABsys to utilize $7M Series B funding for accelerating DNA sequencing platform development

Wellstar International commences Beta Test in Long Term Care Facility

Pharmatek Laboratories meets DEA requirements for developing and manufacturing controlled substances

NMT Medical completes private placement of common stock and warrants for $5.8M

Menopause supplement to bring body back into balance

MedCath to sell Heart Hospital of Austin to St. David's Healthcare Partnership

Domino's Pizza raises $2M during 2009 Thanks and Giving campaign for St. Jude Children's Research Hospital

Dyax announces fourth-quarter and full-year 2009 financial results

Merge Healthcare signs reseller agreement with Orion Health

Anpath Group, ESI report increased quarterly revenues in fiscal third-quarter results

Fourth-quarter and full-year 2009 results announced by Celsion

FDA approved cannabis medicines needed for veterans to relieve symptoms of PTSD

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News